Dialybrid

Dialybrid is a provider of a vascular access solution for hemodialysis. From its funding announcement.

€15M Series ARaised 2 days agoCantù, ItalyOtherItaly
Visit website →

In their own words

What Dialybrid says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "provider of a vascular access solution for hemodialysis". Source

Research and development

Public signal Read from the company's own description of what the funding supports.

Why now

Where Dialybrid is today

Dialybrid announced a Series A round of €15M on 22 September 2026, led by XGEN Venture.

Latest round
Series A
Amount
€15M
Announced
22 September 2026
Headquarters
Cantù, Italy
Sector
Other
Investors
Also participating
Relevant leadership
CEO Francesco Giovanni Greco

Momentum AfterRaise intelligence

AfterRaise Score

67
Building momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
12/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 22 September 2026
    €15M Series A
    Led by XGEN Venture.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Research programme expansion
  • Scientific team growth
  • Repeatable go-to-market build
  • First senior commercial hires

Opportunities this could create

  • Operations hiring
  • Scientific advisers
  • Research operations
  • Specialist suppliers
  • Commercial leadership

Based on the Other sector, a Series A round and the priorities the company itself set out. Not a statement of fact.

Medium momentum2 connected signals
  • 22 September 2026€15M Series A announced
  • 22 September 2026Stated priority: research and development

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Dialybrid is open to

Not yet specified

Dialybrid has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Dialybrid

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Dialybrid?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Other companies

See the sector